Dear all,
I would like to discuss the topic of policy makers: governemental (Industry, Economics, Health) at the national level and european level, non governemental (patients’ associations), and most importantly pharma companies.
The purpose of this topic would be to establish the list of the policy makers and the plan on how to approach them.
Denis